China Digest: TYK Medicines bags $62m; TAOS Data raises $47m led by Matrix Partners China
Source:
Jan Antonin Kolar/Unsplash
May 24, 2021
TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round led by Sealand Innovation, while TAOS Data has secured $47 million in a Series B round led by Matrix Partners China.
TYK Medicines bags nearly $62m Series B+
Chinese biopharmaceutical firm TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round of financing led by Sealand Innovation, a 17.6 billion yuan ($2.7 billion) fund owned by Sealand Securities, according to a company statement on Monday.
The round also saw participation from Haibang Investment and Zheshang Venture Capital, a Hangzhou-based investment firm that has invested in fresh produce e-commerce platform MissFresh; ride-hailing player Caocao; and cloud video provider Arcvideo Tech, among others.